The Italian Society of Infectious and Tropical Diseases (SIMIT) of the Technical Health Committee, Ministry of Health (Sections L and M) of Italy have supported recommendations for the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. This publication summarizes the latest updates to the 2016 version of the Italian Guidelines for the management of HIV-1 infected patients and the use of antiretroviral drugs. In particular, new recommendations were released concerning the following topics: estimate of the HIV continuum of care in Italy, optimal timing and preferred drug combinations for starting antiretroviral therapy, treatment optimization, and pre-exposure prophilaxis (PrEP). For a complete review of clinical and therapeutic relevant topics we refer the reader to the extended version of the Guidelines.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons : update 2016 / A. Antinori, A. Di Biagio, S. Marcotullio, M. Andreoni, A. Chirianni, A. d'Arminio Monforte, M. Galli, F. Mazzotta, C. Mussini, M. Puoti, A. Lazzarin. - In: NEW MICROBIOLOGICA. - ISSN 1121-7138. - 40:2(2017 Apr), pp. 86-98.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons : update 2016

A. d'Arminio Monforte;M. Galli;A. Lazzarin
2017-04

Abstract

The Italian Society of Infectious and Tropical Diseases (SIMIT) of the Technical Health Committee, Ministry of Health (Sections L and M) of Italy have supported recommendations for the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. This publication summarizes the latest updates to the 2016 version of the Italian Guidelines for the management of HIV-1 infected patients and the use of antiretroviral drugs. In particular, new recommendations were released concerning the following topics: estimate of the HIV continuum of care in Italy, optimal timing and preferred drug combinations for starting antiretroviral therapy, treatment optimization, and pre-exposure prophilaxis (PrEP). For a complete review of clinical and therapeutic relevant topics we refer the reader to the extended version of the Guidelines.
Guidelines; HIV; Italy; antiretroviral agents; Anti-HIV Agents; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; Health Policy; Italy; HIV-1; Practice Guidelines as Topic
Settore MED/07 - Microbiologia e Microbiologia Clinica
http://www.newmicrobiologica.org/PUB/allegati_pdf/2017/2/86.pdf
Article (author)
File in questo prodotto:
File Dimensione Formato  
86.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 496.68 kB
Formato Adobe PDF
496.68 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/623249
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 27
social impact